Effects of Semaglutide in HIV-Associated Lipohypertrophy
Effects of Semaglutide in HIV-Associated Lipohypertrophy
Active, not recruiting · NCT04019197 · Registry updated 2026-05-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Effects of Semaglutide in HIV-Associated Lipohypertrophy | AIDS, Blood-Borne Infections, Body Weight, Genital Diseases, HIV infectious disease, Infections, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, Signs and Symptoms, Slow Virus Diseases, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, nutritional disorder, obesity disorder, overnutrition, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Active, not recruiting | Phase 2 | 2026-05-04 | NCT04019197 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Case Western Reserve University | Cleveland | United States | 219 |
| Medical University of South Carolina | Charleston | United States | 628 |